N R CHOWDHURY
Overview
Explore the profile of N R CHOWDHURY including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Chhotray G, Pal B, Khuntia H, CHOWDHURY N, Chakraborty S, Yamasaki S, et al.
Epidemiol Infect
. 2002 May;
128(2):131-8.
PMID: 12002529
An epidemiological study was carried out to find out the aetiological agent for diarrhoeal disorders in the cyclone and flood affected areas of Orissa, India. Rectal swabs collected from 107...
3.
Sinha S, Chowdhury P, CHOWDHURY N, Kamruzzaman M, Faruque S, Ramamurthy T, et al.
Indian J Med Res
. 2002 Mar;
114:83-9.
PMID: 11873402
Background & Objectives: While investigating a cholera outbreak in south India, toxigenic and nontoxigenic strains of Vibrio cholerae O1 were isolated from patients and from the environment, respectively. This study...
4.
Bhuiyan N, Ansaruzzaman M, Kamruzzaman M, Alam K, CHOWDHURY N, Nishibuchi M, et al.
J Clin Microbiol
. 2002 Jan;
40(1):284-6.
PMID: 11773134
Sixty-six strains of Vibrio parahaemolyticus belonging to 14 serotypes were isolated from hospitalized patients in Dhaka, Bangladesh, from January 1998 to December 2000. Among these, 48 strains belonging to four...
5.
Ghosh S, Sappal B, Kalpana G, Lee S, Chowdhury J, CHOWDHURY N
J Biol Chem
. 2001 Sep;
276(45):42108-15.
PMID: 11546782
Genetic lesions of bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) completely or partially abolish hepatic bilirubin glucuronidation, causing Crigler-Najjar syndrome type 1 or 2, respectively. Clinical observations indicate that some mutant forms of human...
6.
Kadakol A, Sappal B, Ghosh S, Lowenheim M, Chowdhury A, Chowdhury S, et al.
J Med Genet
. 2001 May;
38(4):244-9.
PMID: 11370628
No abstract available.
7.
Ramamurthy T, Rajendran K, Garg P, Shimada T, Basu A, CHOWDHURY N, et al.
Indian J Med Res
. 2000 Nov;
112:78-85.
PMID: 11094852
Background & Objectives: Antimicrobial resistance among Vibrio cholerae has been monitored for several years in Calcutta. To investigate the changing trends in multidrug resistance (MDR) among different serogroups of V....
8.
CHOWDHURY N, Chakraborty S, Ramamurthy T, Nishibuchi M, Yamasaki S, Takeda Y, et al.
Emerg Infect Dis
. 2000 Nov;
6(6):631-6.
PMID: 11076722
The upsurge in worldwide incidence of Vibrio parahaemolyticus infection in the last 5 years has been attributed to the recent appearance of three serotypes with pandemic potential: O3:K6, O4:K68, and...
9.
Garg P, Nandy R, Chaudhury P, CHOWDHURY N, De K, Ramamurthy T, et al.
J Clin Microbiol
. 2000 Nov;
38(11):4249-53.
PMID: 11060101
The toxigenic Inaba serotype of Vibrio cholerae O1 biotype El Tor reappeared in India in 1998 and 1999, almost 10 years after its last dominance in Calcutta in 1989. Extensive...
10.
CHOWDHURY N, Chakraborty S, Eampokalap B, Chaicumpa W, Chongsa-nguan M, Moolasart P, et al.
Epidemiol Infect
. 2000 Nov;
125(1):17-25.
PMID: 11057955
Active surveillance of Vibrio parahaemolyticus infection among hospitalized patients in Calcutta, India, showed the appearance of the O4:K68 serovar for the first time in March 1998 alongside the continued predominant...